Vestibular Innovation in Pain

Last updated: July 1, 2025
Sponsor: Icahn School of Medicine at Mount Sinai
Overall Status: Completed

Phase

N/A

Condition

Pain

Pain (Pediatric)

Treatment

Vestibulocortical Stimulation

Clinical Study ID

NCT06559839
STUDY-23-00885
  • Ages 18-99
  • All Genders

Study Summary

The VIP trial will assess the effectiveness, tolerability, and durability of effect of vestibulocortical stimulation (VCS) - a safe & cost-effective bedside technique - in treating pain, fatigue & related symptoms using validated patient-reported outcomes. Data from this trial will be used to guide optimized treatment protocols in future randomized controlled trials and help inform the implementation of VCS into standard clinical practice.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Provision of signed and dated informed consent form

  • Age equal to or >18 years old

  • Stated interest in and willingness to receive VCS and to complete the online patientreported outcomes before and after the procedure.

  • Owns or has access to a smart phone or computer to complete outcome measures

  • Diagnosis of one of the following:

  • Fibromyalgia (FM), with at least a 4/10 average baseline pain on the numericrating scale at the time of inclusion.

  • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  • Long-COVID

  • Post Treatment Lyme Disease Syndrome (PTLDS)

Exclusion

Exclusion Criteria:

An individual with any of the following criteria will be excluded from participation in this study:

  • History of tympanic membrane injury, rupture, or surgery

  • Including tympanostomy, or "ear tubes," and/or cochlear implant.

  • Ear infection within the last 3 months, or current ear pain.

  • Current pregnancy

  • Bipolar Disorder

  • History of seizures (including non-epileptiform seizures)

  • History of syncope

  • Inability to lay supine for 30 minutes

  • Clinically significant medical, psychological, or behavioral conditions that, in theopinion of the investigator, would compromise participation in the study

  • Not fluent in English

  • History of or current Meniere's Disease

  • History of myocardial infarction (MI), stroke or TIA, or coronary artery bypassgraft (CABG) in the last three months

  • History of hospitalization for severe hypertension

  • History of vestibular schwannoma or meningioma resection.

Study Design

Total Participants: 39
Treatment Group(s): 1
Primary Treatment: Vestibulocortical Stimulation
Phase:
Study Start date:
October 01, 2024
Estimated Completion Date:
March 06, 2025

Study Description

VCS is a form of non-invasive neuromodulation whereby cold water is irrigated into the external ear canal.

Connect with a study center

  • Mount Sinai West

    New York, New York 10019
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.